酒精相关肝病早期肝移植生存极佳但有害饮酒率更高
单中心回顾性研究纳入2010至2020年708例初次肝移植受者,其中酒精相关肝病且移植前戒酒不足6个月者110例(15.5%)为早期肝移植组。早期肝移植组移植后生存与戒酒超过6个月组相似且优于非酒精相关肝病组,但移植后饮酒及有害饮酒更常见。
要点
- 早期肝移植组移植后生存与戒酒超过6个月组相似(HR 1.31,P=.30),优于非酒精相关肝病组(HR 1.68,P=.04)。
- 早期肝移植组移植后饮酒(40.9% vs 21.8%,P<.001)及有害饮酒(31.2% vs 16.0%,P=.002)均高于戒酒超过6个月组。
- 单因素分析中有害饮酒与移植后死亡相关(HR 1.69,P=.03),多因素回归中未达统计学显著(HR 1.54,P=.10)。
核心结论
- 因酒精相关肝病接受早期肝移植的患者在移植后10年内生存与其它诊断相似或更优,尽管移植后饮酒发生率更高。
研究设计与样本
- 单中心回顾性研究,纳入2010年至2020年期间初次肝移植受者,随访至2022年7月1日,共708例。
- 早期肝移植组110例(15.5%)为酒精相关肝病且移植前戒酒不足6个月;戒酒超过6个月组234例(33.1%);非酒精相关肝病组364例(51.4%)。
- 采用log rank检验、Cox模型和Kaplan-Meier法进行生存分析;Cox模型识别与死亡相关的变量,逻辑回归识别与移植后饮酒相关的变量。
主要发现
- 中位随访4.6年(四分位距2.6-7.3年);早期肝移植组更年轻(P=.001),移植前中位戒酒时间为61.5天。
- 调整Cox模型显示,早期肝移植组与戒酒超过6个月组移植后生存相似(HR 1.31,P=.30),且优于非酒精相关肝病组(HR 1.68,P=.04)。
- 早期肝移植组移植后饮酒(40.9% vs 21.8%,P<.001)及有害饮酒(31.2% vs 16.0%,P=.002)均高于戒酒超过6个月组。
- 单因素分析中有害饮酒与移植后死亡相关(HR 1.69,P=.03),但多因素回归中未达统计学显著(HR 1.54,P=.10)。
- 失代偿性酒精相关肝病复发在早期肝移植组有更多趋势(9.1% vs 4.4%,P=.09)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Early liver transplantation (LT) for alcohol-associated liver disease (ALD) has increased worldwide. Short-term outcomes have been favorable, but data on longer-term outcomes are lacking. METHODS: Single-center retrospective study of primary LT recipients between 2010 and 2020, with follow-up through July 1, 2022. Survival analysis was performed using log rank, Cox models, and Kaplan-Meier method. Cox models were created to identify variables associated with mortality; logistic regression to identify variables associated with post-LT alcohol use. RESULTS: Of 708 patients who underwent LT, 110 (15.5%) had ALD and abstinence <6 months prior to LT (ELT), 234 (33.1%) had ALD and alcohol abstinence >6 months (SLT), and 364 (51.4%) had non-ALD diagnoses. Median follow-up was 4.6 years (interquartile range, 2.6-7.3 years). ELT recipients were younger (P = .001) with median abstinence pre-LT of 61.5 days. On adjusted Cox model, post-LT survival was similar in ELT and SLT (hazard ratio [HR], 1.31; P = .30) and superior to non-ALD (HR, 1.68; P = .04). Alcohol use (40.9% vs 21.8%; P < .001) and harmful alcohol use (31.2% vs 16.0%; P = .002) were more common in ELT recipients. Harmful alcohol use was associated with post-LT mortality on univariate (HR, 1.69; P = .03), but not multivariable regression (HR, 1.54; P = .10). Recurrence of decompensated ALD trended toward more common in ELT (9.1% vs 4.4%; P = .09). Greater than 6 months pre-LT abstinence was associated with a decreased risk of harmful alcohol use (odds ratio, 0.42; P = .001), but not in a multivariable model (odds ratio, 0.71; P = .33). CONCLUSIONS: Patients who undergo ELT for ALD have similar or better survival than other diagnoses in the first 10 years after LT despite a higher incidence of post-LT alcohol use.
引用
- Musto JA, Palmer G, Nemer M, et al. Early Liver Transplant for Alcohol-associated Liver Disease Has Excellent Survival but Higher Rates of Harmful Alcohol Use. Clin Gastroenterol Hepatol. 2024. PMID: 38729395. doi:10.1016/j.cgh.2024.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。